I am a pediatric gastroenterologist with expertise in pediatric nutrition and obesity at Cincinnati Children's Hospital Medical Center. I am a Professor at the University of Cincinnati, the Program Director of our Advanced Nutrition Fellowship and the Associate Program Director of our Steatohepatitis Center. My clinical research is focused on MASLD.

Gina Madison is the Executive Director and a Board Member of Liver Education Advocates (LEA), a national nonprofit dedicated to advancing liver health through education, awareness, advocacy, and patient support. Since joining LEA in 2019, she has helped expand the organization's national reach through innovative education programs, community partnerships, and culturally responsive initiatives that empower individuals affected by liver disease.

Dr. Espy Schaefer is a hepatologist and GI/liver hospitalist at Mass General Brigham, where she has served on the faculty since completing her residency and GI fellowship at MGH. She holds an undergraduate degree from Yale and an MD/MPH from Columbia University. After starting her research career as a basic and translational investigator in viral hepatitis, she co-founded the MGB alcohol liver disease clinic and biorepository which forms the basis of much of her current clinical research, including integrated addiction and hepatology care and biomarkers in ALD. Dr.

I am a transplant hepatologist at Thomas Jeffersno University. I have a special interest in alcohol associated liver disease and alcohol use disorder.

Dr. Rebecca Roediger's clinical and research interest focuses on advancing innovative models of integrated care for patients with alcohol related liver disease and alcohol use disorder. She is a transplant hepatologist at Weill Cornell Medicine and Medical Director of the Center for Alcohol and Liver Medicine, an integrated addiction and hepatology program dedicated to the treatment of alcohol-associated liver disease. She previously established and served as Medical Director of METRIC, Montefiore Einstein's multidisciplinary alcohol-related liver disease clinic. Dr.

Dr. Sonali Paul is Associate Professor of Medicine and Section Chief of Gastroenterology, Hepatology, and Nutrition at the University of Chicago. A transplant hepatologist, her clinical and research interests focus on metabolic dysfunction–associated steatotic liver disease (MASLD), obesity medicine, and liver transplantation.

I am an Associate Professor of Medicine in the Karsh Division of Gastroenterology and Hepatology and serve as Medical Director of the Liver Cancer Program at Cedars-Sinai Cancer. My research focuses on clinical and translational studies in liver cancer, with particular expertise in liver cirrhosis epidemiology, risk stratification, surveillance, early cancer detection, diagnosis, and treatment.

Dr. Brittany Bromfield earned her medical degree from the University of the West Indies in Jamaica and completed her internal medicine residency at the University of Pittsburgh Medical Education Program. She is currently a gastroenterology and hepatology fellow at Brigham and Women's Hospital. Her clinical and research interests include alcohol-related liver disease (ALD), MetALD, MASLD, and obesity, with a focus on the intersection of metabolic dysfunction and addiction.

Jennifer Onwochei, MD, is a transplant hepatologist and Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at Northwell Health. Her clinical and academic interests include liver transplantation, community health, global outreach, and medical education. Dr. Onwochei is committed to advancing equitable liver care through patient-centered practice, mentorship, and community engagement.

Dr. Vos is a Professor of Pediatrics and Associate Chair of Translational Research in the Department of Pediatrics at Michigan State University, as well as the Director of Research for Helen DeVos Children's Hospital at Corewell Health. She has investigated MASLD in children for more than 20 years, contributing to improved dietary strategies and advancing the understanding of emerging therapies and biomarkers. She has authored over 150 peer‑reviewed publications on MASLD and related topics and has maintained continuous NIH funding since 2007. Dr.